Our current MR findings shed further light on the differential effects of LDL-c lowering through HMGCR and ACLY inhibition, highlighted by the opposing directionality of their MR associations with some anthropometric traits and T2DM risk. Here, ACLY is linked to type 2 diabetes mellitus.